| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/16/2004 | EP1427413A2 2-aroylimidazole compounds for treating cancer |
| 06/16/2004 | EP1427412A1 Methods of treating cytokine mediated diseases |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1200429B1 1-cycloalkylpyrazoyl-benzoyl derivatives |
| 06/16/2004 | EP0960104B1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors |
| 06/16/2004 | EP0807105B1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
| 06/16/2004 | CN1505629A Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 06/16/2004 | CN1505628A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505627A Cyclic amp-specific phosphodiesterase inhibitors |
| 06/16/2004 | CN1505626A Novel benzylpiperidine compound |
| 06/16/2004 | CN1505625A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505624A Piperazino-derivatives and their use as pde4 inhibitor |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/15/2004 | US6750348 Protective effects against infection by hiv through binding to chemokine receptors, including cxcr4 and ccr5;n-(2-pyridinylmethyl)-n'-(2-(phenylureido)ethyl)-n'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine |
| 06/15/2004 | US6750338 Process for making 5-substituted pyrazoles |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6750237 Pharmaceutical formulations containing zolmitriptan |
| 06/15/2004 | US6750231 Skin disorders; gastrointestinal disorders |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750215 Antitumor agents; anticancer agents |
| 06/15/2004 | US6750024 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 06/10/2004 | WO2004048392A1 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
| 06/10/2004 | WO2004048371A1 Indolyl derivatives |
| 06/10/2004 | WO2004048370A1 Antibacterial compounds |
| 06/10/2004 | WO2004048365A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 06/10/2004 | WO2004048350A2 Oxazolidinones as antibacterial agents |
| 06/10/2004 | WO2004048349A1 Farnesoid x receptor agonists |
| 06/10/2004 | WO2004048348A1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) ones used as herbicides |
| 06/10/2004 | WO2004048345A2 2,5-diketopiperazines for the treatment of obesity |
| 06/10/2004 | WO2004048343A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/10/2004 | WO2004048330A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 06/10/2004 | WO2004047730A2 Compounds for inhibition of hiv infection by blocking hiv entry |
| 06/10/2004 | WO2004032845A3 R-nsaid esters and their use |
| 06/10/2004 | WO2004032834A3 Thrombin inhibitors |
| 06/10/2004 | WO2003066005A3 Ansamycins having improved pharmacological and biological properties |
| 06/10/2004 | WO2003059265A3 Compositions and methods for treating heart failure |
| 06/10/2004 | US20040110956 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110811 3-carbonyl- and sulfonyl derivatives: e.g., 1-Benzyl-3-naphthylcarbonyl-5,5-diphenylimidazolidine -2,4-dione; chymase and/or tryptase inhibition activity; especially treating chorioretinopathy, glaucoma, myopia or asthenopia. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110808 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110804 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 06/10/2004 | US20040110802 Antibacterial benzoic acid derivatives |
| 06/10/2004 | US20040110798 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 06/10/2004 | US20040110797 Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors |
| 06/10/2004 | US20040110793 Heterocyclo inhibitors of potassium channel function |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110757 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis |
| 06/10/2004 | US20040110756 Anthracene-9-yl-[4-(4-nitro-phenyl)-piperazine-1-yl]-methanone for example; antitumor agents for benign and malignant tumors |
| 06/10/2004 | US20040110749 Crop and weed selectivity |
| 06/10/2004 | US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 06/10/2004 | US20040110745 Serotonin (5-HT) receptor antagonists; psychiatric, eating , sexual, panic, psychological, gastrointestinal, cardiovascular, and sleep disorders; headaches, dementia |
| 06/10/2004 | US20040110741 Substituted pyrazolyl compounds for the treatment of inflammation |
| 06/10/2004 | US20040110640 Herbicidal substituted benzoylpyrazoles |
| 06/10/2004 | US20040109890 Tablets quickly disintegrated in oral cavity |
| 06/10/2004 | CA2507628A1 Oxazolidinones as antibacterial agents |
| 06/10/2004 | CA2507468A1 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
| 06/10/2004 | CA2506843A1 2,5-diketopiperazines for the treatment of obesity |
| 06/10/2004 | CA2502970A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/09/2004 | EP1426372A1 2-Oxadiazolechromone derivatives |
| 06/09/2004 | EP1426365A1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same |
| 06/09/2004 | EP1426364A1 Imidazole-derivatives as factor Xa inhibitors |
| 06/09/2004 | EP1425272A1 Optical isomers of an iloperidone metabolite |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425014A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | EP1299380B1 Indole derivatives useful for the treatment of cns disorders |
| 06/09/2004 | EP1286998B1 Oxazolidinone derivatives with antibiotic activity |
| 06/09/2004 | EP1251129B1 Pyrimidine derivatives having antitumor effect |
| 06/09/2004 | EP1202966B1 Piperidine alcohols |
| 06/09/2004 | EP1196412B1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 06/09/2004 | EP1100795B1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 06/09/2004 | DE10255416A1 Substituierte 2-Aryl-1,2,4-triazin-3,5-di(thi)one Substituted 2-aryl-1,2,4-triazine-3,5-di (thi) ones |
| 06/09/2004 | CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503787A Novel compounds |
| 06/09/2004 | CN1503786A Large conductance calcium-activated k channel opener |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1503673A antiinflammation agents |
| 06/09/2004 | CN1502614A Intermediate for priparing taxanes derivative |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152873C Novel diphenyl-piperidine derivate |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152868C Substituted aryl ketones |
| 06/09/2004 | CN1152866C Benzimidazoles, production thereof and use thereof medicaments |
| 06/09/2004 | CN1152716C Farnesyl protein transferase inhbitors with internal radiosensitizing |
| 06/08/2004 | US6747158 Anticoagulants |
| 06/08/2004 | US6747050 Isoxazoline derivative and a process for the preparation thereof |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747030 Cis-6-(3,5-dimethylpiperazin-1-yl)-5-methoxy-1-(2'-methyl-4'-( 5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl)indoline, its hydrochloride salt, or another pharmaceutically acceptable salt thereof; antidepressants |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |